Vasopressor Ppt and Latest 50 Published articles

Vasopressor: causing an increase in blood pressure by constricting the arteries;  a substance that has such an effect.

Cardiovascular  management of septic  shock
Cardiovascular%20management%20of%20septic%20shock.ppt

Vasoactive  Agents in Emergency Care
by Susan  P. Torrey, M.D., FACEP
http://vietnamem.org/ubr_uploads/MD_2012/EN_Vasopressors.ppt

Updates in Haemodynamics Support
by Dr.  OY Tam, Dr. LL Chang
ICU-Surgical%20Inter-departmental%20Grand%20Round%20v2.ppt

Inotropes & Vasopressors
by Dr  Cathy Armstrong
Inotropesvasopressors.ppt

Pressors
by Scott  Forman, D.O.
pcommed.com/Pressors.ppt

Vasoactive  drugs in the intensive  care unit
by Holmes, Cheryl L
vasoactive drugs.ppt

Steroids  in Vasopressor-Dependent Sepsis
by Melissa  Hynes, MD
SteroidSepsis.ppt

Overview  and Use of Pressors
Emphasis on Cardiogenic, Neurogenic, and Septic Shock
by Alexander  R. Raines, M.D
Overview%20and%20Use%20of%20Pressors%20%20%20%20Raines.ppt

Arginine  Vasopressin in Advanced  Vasodilatory Shock
http://www.anesthesia21.com/board/data/DeptNews/AVP.ppt

Management of Septic Shock
http://sparmy.com/Quake%20stuff/hypertension/SEPSISrevised.PPT

Latest 50 Publications

1. Effects of intravenous vasopressor on spread of spinal anesthesia with 0.5% hyperbaric bupivacaine for caesarean delivery.
2. A systematic review of the evidence supporting a role for vasopressor support in acute SCI.
3. Alpha-2 agonists to reduce vasopressor requirements in septic shock?
4. Are vasopressor use and mechanical ventilation the only predictors of worse outcome for fulminant Clostridium difficile infection?
5. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial.
6. Best vasopressor for advanced vasodilatory shock: should vasopressin be part of the mix?
7. Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo.
8. Challenging the rationale of routine vasopressor therapy for management of hypotension.
9. Circuit start during continuous renal replacement therapy in vasopressor-dependent patients: the impact of a slow blood flow protocol.
10. Early systemic hypotension and vasopressor support in low birth weight infants: impact on neurodevelopment.
11. Early vasopressor use in critical injury is associated with mortality independent from volume status.
12. Editorial note on: a systematic review of the evidence supporting a role for vasopressor support in acute SCI.
13. Effects of vasopressor administration on the outcomes of microsurgical breast reconstruction.
14. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II.
15. Human liver enzymes responsible for metabolic elimination of tyramine; a vasopressor agent from daily food.
16. Hydrocortisone for hypotension and vasopressor dependence in preterm neonates: a meta-analysis.
17. Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressor-dependent shock.
18. Inotrope and vasopressor therapy of septic shock.
19. Inotrope and vasopressor therapy of septic shock.
20. Is a relatively high pre-spinal heart rate associated with reduced efficacy of prophylactic vasopressor during spinal anaesthesia for caesarean section?
21. Norepinephrine: more of a neurohormone than a vasopressor.
22. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study.
23. Performance of cardiac output measurement derived from arterial pressure waveform analysis in patients requiring high-dose vasopressor therapy.
24. Persistent Ventricular Fibrillation during Therapeutic Hypothermia and Prolonged High-dose Vasopressor Therapy: Case Report.
25. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock.
26. Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study.
27. Refractory hypotension and ECG changes in a case of nicorandil and lisinopril overdose and role of vasopressor in management.
28. Retrospective study of association between choice of vasopressor given during spinal anaesthesia for high-risk caesarean delivery and fetal pH.
29. Review article: inotrope and vasopressor use in the emergency department.
30. Review of vasopressor therapy in the setting of vasodilatory shock.
31. Right ventricular failure resulting from pressure overload: role of intra-aortic balloon counterpulsation and vasopressor therapy.
32. Role of vasopressor administration in patients with acute neurologic injury.
33. Safety of vasopressor use in head and neck microvascular reconstruction: a prospective observational study.
34. The association of lactate and vasopressor need for mortality prediction in survivors of cardiac arrest.
35. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type.
36. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
37. The effect of maternal and fetal β2-adrenoceptor and nitric oxide synthase genotype on vasopressor requirement and fetal acid-base status during spinal anesthesia for cesarean delivery.
38. The head-down tilt position decreases vasopressor requirement during hypotension following induction of anaesthesia in patients undergoing elective coronary artery bypass graft and valvular heart surgeries.
39. The relationship between vasopressor dose and anastomotic leak in colon surgery: an experimental trial.
40. The Role of Clinical Decision Support Tools to Reduce Blood Pressure Variability in Critically Ill Patients Receiving Vasopressor Support.
41. Use of inotropes and vasopressor agents in critically ill patients.
42. Vasopressor administration and sepsis: a survey of Canadian intensivists.
43. Vasopressor agents after experimental brain death: effects of dopamine and vasopressin on vitality of the small gut.
44. Vasopressor and heart rate responses to systemic administration of bombesin in anesthetized rats.
45. Vasopressor nerve responses in the pithed rat, previously identified as α2-adrenoceptor mediated, may be α1D-adrenoceptor mediated.
46. Vasopressor use and effect on blood pressure after severe adult traumatic brain injury.
47. Vasopressor Use in Adult Patients.
48. Vasopressor use in free tissue transfer surgery.
49. Which vasopressor for caesarean section?
50. α(1D)-Adrenoceptor regulates the vasopressor action of α(1A)-adrenoceptor in mesenteric vascular bed of α(1D)-adrenoceptor knockout mice.